Expert Opinion on Therapeutic Patents This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Trace amine associated receptor 1 (TAAR1) modulators: a patent review (2010-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - December 25, 2019 Category: Drugs & Pharmacology Authors: Michele Tonelli E Cichero Source Type: research

A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - December 25, 2019 Category: Drugs & Pharmacology Authors: Sida Shen Alan P. Kozikowski Source Type: research

Current status of GPR40/FFAR1 modulators in medicinal chemistry (2016 –2019): a patent review
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - December 23, 2019 Category: Drugs & Pharmacology Authors: Zheng Li Zongtao Zhou Luyong Zhang Source Type: research

A patent review of BRD4 inhibitors (2013-2019)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - December 23, 2019 Category: Drugs & Pharmacology Authors: Tian Lu Wenchao Lu Cheng Luo Source Type: research

Peroxisome proliferator-activated receptor agonists and antagonists: a patent review (2014-present)
. (Source: Expert Opinion on Therapeutic Patents)
Source: Expert Opinion on Therapeutic Patents - December 23, 2019 Category: Drugs & Pharmacology Authors: Ichiro Takada Makoto Makishima Source Type: research